Short-term and long-term models of doxorubicin-induced cardiomyopathy in rats: A comparison of functional and histopathological changes.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Experimental and Toxicological Pathology

• Publication date

  2017-04-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.etp.2017.01.004PMID 28153388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research.

  2016cited by this paper
• An Upgrade on the Rabbit Model of Anthracycline-Induced Cardiomyopathy: Shorter Protocol, Reduced Mortality, and Higher Incidence of Overt Dilated Cardiomyopathy

  2015cited by this paper
• A short-time model to study relevant indices of cardiotoxicity of doxorubicin in the rat

  2013cited by this paper
• Early detection of doxorubicin myocardial injury by ultrasonic tissue characterization in an experimental animal model

  2012cited by this paper
• Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy.

  2011cited by this paper
• Strain echocardiography combined with pharmacological stress test for early detection of anthracycline induced cardiomyopathy.

  2011cited by this paper
• Effects of Angiotensin-1 Converting Enzyme Inhibition on Oxidative Stress and Bradykinin Receptor Expression During Doxorubicin-induced Cardiomyopathy in Rats

  2008cited by this paper
• Doxorubicin cardiotoxicity in the rat: an in vivo characterization.

  2007cited by this paper
• Effect of lycopene on doxorubicin-induced cardiotoxicity: an echocardiographic, histological and morphometrical assessment.

  2007cited by this paper
• Long-term and short-term models for studying anthracycline cardiotoxicity and protectors

  2007cited by this paper
• Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.

  2007cited by this paper
• Serial Assessment of Myocardial Properties Using Cyclic Variation of Integrated Backscatter in an Adriamycin-Induced Cardiomyopathy Rat Model

  2005cited by this paper
• Animal models of heart failure: what is new?

  2005cited by this paper
• Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin

  2004cited by this paper
• Erdosteine prevents doxorubicin-induced cardiotoxicity in rats.

  2003cited by this paper
• Dystrophin‐deficient cardiomyocytes are abnormally vulnerable to mechanical stress‐induced contractile failure and injury

  2001cited by this paper
• The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats.

  2001cited by this paper
• Prevention of doxorubicin (adriamycin)-induced cardiomyopathy by simultaneous administration of angiotensin-converting enzyme inhibitor assessed by acoustic densitometry.

  2000cited by this paper
• Progressive cardiac dysfunction in adriamycin‐induced cardiomyopathy rats

  2000cited by this paper
• Adriamycin-induced heart failure: mechanisms and modulation

  2000cited by this paper
• A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracic echocardiography.

  1998cited by this paper
• Cardiac energy metabolism at several stages of adriamycin-induced heart failure in rats.

  1997cited by this paper
• Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research.

  1997cited by this paper
• Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats.

  1994cited by this paper
• Myocardial substrate utilization and left ventricular function in adriamycin cardiomyopathy.

  1993cited by this paper
• Metaiodobenzylguanidine: evaluation of its potential as a tracer for monitoring doxorubicin cardiomyopathy.

  1993cited by this paper
• Ultrastructural features of Adriamycin-induced skeletal and cardiac muscle toxicity.

  1985cited by this paper
• Experimental models of heart failure.

  1985cited by this paper
• Some recent advances in cardiac pathology.

  1979cited by this paper
• Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.

  1977cited by this paper
• Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy.

  1976cited by this paper
• An anthracycline antibiotic-induced cardiomyopathy in rabbits.

  1974cited by this paper
• An anthracycline antibiotic-induced cardiomyopathy in rabbits.

  1974cited by this paper
• [Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)].

  1967cited by this paper

• Targeted nano delivery of p53 DNA and carvedilol for the treatment of dilated cardiomyopathy in a rat model.

  2026cites this paper
• Astaxanthin mitigates cardiac toxicity induced via doxorubicin by alleviating mitochondrial fission and autophagy in rats

  2025cites this paper
• Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies

  2025cites this paper
• Consistent RNA expression and RNA modification patterns in cardiotoxicity induced by Matrine and Evodiamine

  2025cites this paper
• USP14 Modulates Cell Pyroptosis and Ameliorates Doxorubicin-Induced Cardiotoxicity by Deubiquitinating and Stabilizing SIRT3.

  2024cites this paper
• Cardiac Rehabilitation by Pulmonary Artery Banding after Induced Dilated Cardiomyopathy: A Pilot Study on a Rodent Model

  2024influential citation
• Poly (ADP-ribose) polymerase pathway inhibitor (Olaparib) upregulates SERCA2a expression and attenuates doxorubicin-induced cardiomyopathy in mice.

  2023cites this paper
• THE DIAGNOSTIC ACCURACY OF RADIOGRAPHIC CARDIAC INDICES IN THE ASSESSMENT OF CARDIOMEGALY AND LEFT ATRIAL ENLARGEMENT IN RATS WITH DILATED CARDIOMYOPATHY: AN EXPERIMENTAL STUDY

  2023influential citation
• Rodent Models of Dilated Cardiomyopathy and Heart Failure for Translational Investigations and Therapeutic Discovery

  2023cites this paper
• In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation

  2022cites this paper
• Efficacy of Different Cumulative Doses of Doxorubicin in the Induction of a Dilated Cardiomyopathy Model in Rats

  2022cites this paper
• Pulmonary Artery Banding for Dilated Cardiomyopathy in Children: Returning to the Bench from Bedside

  2022cites this paper
• The effects of doxorubicin on cardiac calcium homeostasis and contractile function.

  2022cites this paper
• Protein 4.1 family and ion channel proteins interact to regulate the process of heart failure in rats.

  2021cites this paper
• Resistance training improves cardiac function and cardiovascular autonomic control in doxorubicin-induced cardiotoxicity

  2021cites this paper
• Dual integrin αvβ3 and αvβ5 blockade attenuates cardiac dysfunction by reducing fibrosis in a rat model of doxorubicin-induced cardiomyopathy

  2021cites this paper
• [123I]MIBG is a better early marker of anthracycline cardiotoxicity than [18F]FDG: a preclinical SPECT/CT and simultaneous PET/MR study

  2021cites this paper
• Cardioprotective effect of allyl isothiocyanate in a rat model of doxorubicin acute toxicity

  2021cites this paper
• Comparative Therapeutic Potential of Cardioactive Glycosides in Doxorubicin Model of Heart Failure

  2021cites this paper
• What is considered cardiotoxicity of anthracyclines in animal studies

  2020cites this paper
• Modulation of Nrf2 by quercetin in doxorubicin-treated rats

  2020cites this paper
• Myocardial 2D Strain During Long-Term (>5 Years) Follow-Up of Childhood Survivors of Acute Lymphoblastic Leukemia Treated With Anthracyclines.

  2020cites this paper
• Effect of bilateral sympathectomy in a rat model of dilated cardiomyopathy induced by doxorubicin.

  2020cites this paper
• The Efficacy of Squalene in Cardiovascular Disease Risk-A Systematic Review

  2020cites this paper
• Clinical and Research Tools for the Study of Cardiovascular Effects of Cancer Therapy

  2020cites this paper
• RIP1/RIP3/MLKL-mediated necroptosis contributes to vinblastine-induced myocardial damage

  2020cites this paper
• Spontaneously occurring cardiovascular lesions in commonly used laboratory animals

  2019cites this paper
• Doxorubicin-induced Cardiotoxicity and Cardioprotective Agents: Classic and New Players in the Game.

  2019cites this paper
• Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling

  2019cites this paper
• Doxorubicin persistently rewires cardiac circadian homeostasis in mice

  2019cites this paper
• Effect of ghrelin on VEGF-B and connexin-43 in a rat model of doxorubicin-induced cardiomyopathy

  2019cites this paper
• Coenzyme Q10 Cardioprotective Effects Against Doxorubicin-Induced Cardiotoxicity in Wistar Rat

  2019cites this paper
• Cerium oxide nanoparticles: In pursuit of liver protection against doxorubicin-induced injury in rats.

  2018cites this paper
• Toxicity and Safety Evaluation of Doxorubicin-Loaded Cockleshell-Derived Calcium Carbonate Nanoparticle in Dogs

  2018cites this paper
• ROS Redox Regulation of Autophagy in Dilated and Hypertrophic Cardiomyopathy

  2018cites this paper
• Cardiotoxic Effects of Short-Term Doxorubicin Administration: Involvement of Connexin 43 in Calcium Impairment

  2017cites this paper